Ting-hui Y. Liu
Tainan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Psychiatric safety of methylphenidate in adults with major depressive disorder: a 1-year retrospective cohort study of 6,422 patients.
Journal: Psychological medicine
Published: May 05, 2026
Clinical impact of tirzepatide on patients with chronic obstructive pulmonary disease.
Journal: Frontiers in pharmacology
Published: March 25, 2026
A Cautious Integration With AI in the Clinic: A Standardized-Patient Pilot Study of ChatGPT's Reliability in Hamilton Depression Rating Scale Scoring.
Journal: Alpha psychiatry
Published: March 04, 2026
Effectiveness of GLP-1RA vs metformin for diabetes prevention in antipsychotic-treated patients.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: January 20, 2026
Response to the letter regarding "risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine".
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: January 07, 2026
Efficacy of vitamin D supplementation in patients diagnosed with depression: a dose-response meta-analysis of randomized controlled trials.
Journal: Frontiers in nutrition
Published: December 21, 2025
Comparative effectiveness of tirzepatide versus thiazolidinedione in adults with MASLD: a propensity score-matched cohort study.
Journal: Frontiers in pharmacology
Published: December 17, 2025
Effects of cochlear implants on depression, anxiety, and insomnia in adults with bilateral sensorineural hearing loss: a three-year retrospective cohort study of 8964 cochlear implant users.
Journal: Cochlear implants international
Published: December 15, 2025
Sustained effectiveness and safety of esketamine for major depressive disorder: a target trial simulation of real-world data.
Journal: Translational psychiatry
Published: November 27, 2025
Clinical benefits of tirzepatide in patients with steatotic liver disease and cardiometabolic dysfunction.
Journal: Communications medicine
Published: October 19, 2025
Response to the letter regarding "Risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine".
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: September 25, 2025
Association between tirzepatide use and risk of mortality, hospitalization, and suicidal behavior in patients with schizophrenia spectrum disorders: A one-year retrospective cohort study of 3618 patients.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: September 09, 2025
Last Updated: 09/26/2026